LA

Lokesh Anand

Active Director Director DIN 00474345
DIN 00474345 First appointment May 2002 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2002
Shareholding value •••• Premium profile

About Lokesh Anand

Data last updated:

Lokesh Anand is a Director at Isis Pharmaceuticals Private Limited (since 2002). The company operates in Trading. Isis Pharmaceuticals Private Limited reported revenue of ₹6,600 (FY 2024).

DIN 00474345
Primary Designation Director
Industry Trading
First Appointment 10 May 2002
Oldest Company Age 24 yrs
Largest company Isis Pharmaceuticals Private Limited · ₹6,600 (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Isis Pharmaceuticals Private Limited U24231HR2002PTC034882
Director10 May 20022002₹6,600 (FY 2024)Active

Board colleagues of Lokesh Anand

Directorship timeline

Open interactive timeline →
Isis Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Lokesh Anand

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Lokesh Anand

Lokesh Anand currently holds 1 directorship: Isis Pharmaceuticals Private Limited (Director, since 10 May 2002, revenue ₹6,600 (FY 2024)).

Lokesh Anand was first appointed on 10 May 2002 as Director at Isis Pharmaceuticals Private Limited.

The current boards of Lokesh Anand's companies include Jitender Deewan (Isis Pharmaceuticals Private Limited), Sandeep Singh (Isis Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available